MJBizDaily
Congress barely understands hemp THC. Lawmakers should learn and regulate – not ban
Latest Posts
Despite risks, marijuana firms that make or distribute CBD products use e-commerce to build multistate brands
When President Donald Trump penned hemp legalization into law late last year via the Farm Bill, hemp companies obviously cheered. But marijuana entrepreneurs also took careful note, because that landmark…
News March 20Canadian firm DionyMed to acquire L.A. cannabis campus, other assets for $19 million
Toronto-based DionyMed Brands, a multistate cannabis brands operator, said it will acquire the 1.8-acre Los Angeles campus of MM Esperanza 2, also known as MMAC, for $19 million. The campus…
News March 20Australian medical marijuana revenues could hit AU$36 million in 2019
Australia’s medical cannabis market could surpass 15,000 patient application approvals by the end of this year, with industry revenues totaling roughly 36 million Australian dollars ($25 million), according to an…
News March 20US marijuana firm Vireo Health launches on Canadian exchange
Vireo Health, a Minnesota-based multistate operating cannabis company, started trading Wednesday on the Canadian Securities Exchange. Vireo has growing, dispensary and processing operations in six states. Vireo is trading under…
News March 20Marijuana growers find alternative to cloning – tissue culture
Marijuana growers historically have turned to cloning to propagate plant inventory and perpetuate plant genetics. But the art of cloning, where a cultivator takes a rooted cutting of a mother plant…
News March 20US House committee poised to consider cannabis banking bill next week
A bill to provide federal protection for banks serving state-legal marijuana businesses is scheduled for markup by a congressional committee next week, a notable development for cannabis banking legislation. Maxine…
News March 19Amyris closes on potential $300M cannabinoid deal with biotech firm
Amyris, a California-based company focused on wellness products, said it has closed a deal potentially worth $300 million with biotech startup Lavvan to research and develop synthetic cannabinoids.
News March 19Ascent to sell Canadian cannabis assets for CA$41 million
The Supreme Court of British Columbia has approved the sale of financially troubled cannabis firm Ascent Industries for 41.5 million Canadian dollars ($30 million), comprising CA$29 million in cash and the…
News March 19Illinois marijuana firm Grassroots closes $90 million raise to expand operations
Chicago-based Grassroots Cannabis said it completed a $90 million capital raise designed to expand the company’s footprint and operations. Grassroots, a vertically integrated cannabis company that operates in 11 states,…
News March 19












